Sort
82,697 grants matching “vaccine development”
Developmental Research Program
$680,492W. Ian Lipkin · Columbia University Health Sciences · U54 · FY2009 · AI
Development of Vaccines for Chikungunya
$680,462Gary J Nabel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
HTS for copper-activated inhibitors against MRSA
$680,458Olaf Kutsch · University Of Alabama At Birmingham · R01 · FY2018 · AI
Therapy of Dengue with Modified Antibodies in Humanized Mice
$680,444Rebeca Rico-Hesse · Baylor College Of Medicine · R01 · FY2013 · AI
Potent and Safe Inhibitors of B. anthracis Lethal Factor
$680,436Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2009 · AI
Biological Vulnerability to Chlamydia trachomatis in Adolescents and Young Women: the Complex Intersection of Cervicovaginal Microbiome, Cervical Maturation, and Mucosal Immunity
$680,407Loris Y. Hwang · University Of California Los Angeles · R01 · FY2020 · AI
Prevention of Primary HCMV Infection by Vaccinating against HCMV-Encoded IL-10
$680,407Peter A Barry · University Of California At Davis · R01 · FY2016 · AI
NIH TETRAMER CORE FACILITY (INFECTIOUS DISEASES OTHER THAN HIV/AIDS)
$680,367John Altman · Emory University · N01 · FY2022 · AI
Harnessing the Malarial Immunity Omics Landscape in Vaccinated and Unvaccinated Children for Improved Therapeutic Strategies
$680,236Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2024 · AI
Reservoir Targeted Vaccine fo rthe Control of Lyme Borreliosis
$680,208Maria Gomes-Solecki · University Of Tennessee Health Sci Ctr · U01 · FY2010 · CK
Optimization of Small-Molecule Inhibitors of Shiga and Ricin Toxins
$680,143Yuan-Ping Pang · Mayo Clinic Rochester · U01 · FY2012 · AI
Enhancing Discovery of HIV Host Genetics using Drug Abuse and other Interactions
$680,131Eric O Johnson · Research Triangle Institute · R01 · FY2017 · DA
Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines
$680,090Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2019 · AI
HIV-1 Genetic Variation in Infected Individuals
$680,076Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Human Antibodies to HIV-1 by Repertoire Cloning
$680,070Dennis R. Burton · Scripps Research Institute, The · R01 · FY2013 · AI
Innate Immunity Stimulation via CpG ODN in a Non-Human Primate Model of Sporadic Cerebral Amyloid Angiopathy
$680,059Henrieta Scholtzova · New York University School Of Medicine · R01 · FY2017 · NS
Mechanistic studies of BLyS-mediated modulation in HIV-1 Env-specific antibody responses
$680,047Michael Paul Cancro · University Of Pennsylvania · R01 · FY2018 · AI
NONHUMAN PRIMATE CORE QUANT IRAL RNA LABORATORY FOR AIDS VACCINE R&D
$680,011Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2014 · AI
GOALI: Soft Sensing of Key Process Indicators (KPIs) and Critical Process Parameters (CPPs)
$680,000Karl S Booksh · University Of Delaware · · FY2024 · MPS
Non-inferiority trial of a therapeutic vaccine against Chagas disease in naturally-infected rhesus macaques
$679,990Eric Dumonteil · Tulane University Of Louisiana · R01 · FY2025 · AI
Molecular mechanisms governing chikungunya virus binding, tropism, and pathogenesis
$679,987Laurie A. Silva · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
The Functional Significance of CTL Escape
$679,982University Of Wisconsin Madison · R01 · FY2004 · AI
IGF::OT::IGF TESTING OF COMBINATION IMMUNO AND CHEMOPREVENTION STRATEGIES FOR LYNCH SYNDROME GASTROINTESTINAL CANCER
$679,964Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · N01 · FY2015 · CA
Unique Neisseria Meningitidis B Capsular Epitopes
$679,898Gregory R Moe · Children'S Hospital & Res Ctr At Oakland · R01 · FY2009 · AI
Harvard Tanzania HIV/AIDS Clinical Trials Unit
$679,864Wafaie W Fawzi · Harvard School Of Public Health · U01 · FY2010 · AI